IN THE NEWS

Update from Doug Ghertner, President of IPA It is hard to believe that it has been almost a year since we founded and launched the Infusion Providers Alliance (IPA). We started with just a few companies and now have 10 [...]

The Infusion Providers Alliance (“IPA”) writes to request a meeting to share our concerns regarding CGS’s recent reimbursement treatment of certain intravenous drug administration services for complex, rare, and chronic diseases,1 which went into effect on April 8, 2021.

The Infusion Providers Alliance (IPA) is the leading voice for in-office and freestanding ambulatory infusion care, representing more than 870 community-based, non-hospital providers across the United States. Our members are committed to preserving the integrity of the provider-patient relationship in [...]

The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, complex, chronic conditions and the physicians who care for them, are asking the Centers for Medicare and Medicaid Services (CMS) to ensure that beneficiaries enrolled in Medicare Advantage plans continue [...]

The Infusion Providers Alliance (IPA) appreciates the opportunity to comment on the Most Favored Nation model (MFN) interim final rule (IFR)1. The IPA is strongly opposed to the MFN because it will substantially harm patient access to life saving and [...]

Infusion Providers Alliance Responds to Most Favored Nation Drug Policy

New Requirement to Obtain Certain Drugs from CVS Specialty Pharmacy

A new coalition of drug infusion providers has been established to advocate for policies that preserve patients’ access to infused medicines.